Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy.
The genetic manipulation of tumor cells to express immunostimulatory molecules provides a current approach for the analysis of immune reactions against tumor cells in vivo. Experiments with multiple cytokines have demonstrated that an array of different host effector cells can be recruited by different cytokines in vivo, but more studies are necessary to distinguish cytokine-specific effects from as yet uncharacterized influences of different tumor models. A technically feasible clinical application of this approach is to be seen in the generation of vaccines by introducing such immunostimulatory genes into cancer cells and boosting systemic immune reactions against the unmodified cells. The experimental basis of these vaccination studies is critically discussed.
Hock
H
H
Institut für Immunologie, Universitätsklinikum Steglitz, Berlin, BRD.
Dorsch
M
M
Richter
G
G
Kunzendorf
U
U
Krüger-Krasagakes
S
S
Blankenstein
T
T
Qin
Z
Z
Diamantstein
T
T
D000818:Animals; D016207:Cytokines / Q000235:genetics*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D007962:Leukocytes / Q000502:physiology; D016131:Lymphocyte Subsets / Q000502:physiology; D008264:Macrophages / Q000502:physiology; D051379:Mice; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy*
D016207:Cytokines